Chartered Universe
LoginSign Up
Back to Articles
GeneralBusiness Today

Alembic Pharma shares rise 4% on receiving USFDA EIR for Vadodara facility

Source: Business Today

The USFDA conducted the inspection at Alembic Pharmaceuticals' Bioequivalence Facility in Vadodara from March 3 to March 7, 2025. The company had earlier informed the stock exchanges about the completion of the inspection.

Attribution

This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.

Read on Business Today

More Articles

Audit & Standards16 Oct 2026

My Most Hated Subject in School Became My Biggest Advantage

Why every engineer, analyst and product person should learn how finance works. Continue reading on Medium »

Medium — Accounting · Tosin Ilesanmi

Audit & Standards16 Oct 2026

How Much Debt Dooes AI Have?

The simple answer is around $500 Billion with $3 Trillion of commitments, but if that is overleveraged and who stands the most to loose is… Continue reading on Medium »

Medium — Accounting · Dhru Patel

Tax & Compliance16 Oct 2026

Are You Still Paying Taxes From 10+ Years Ago?

A tax client and I were discussing their business and personal expenses for getting their most recent tax return filed, and they casually… Continue reading on Medium »

Medium — Tax & Accounting · Dwayne J Briscoe - Bookkeeping-Results, LLC

Tax & Compliance16 Oct 2026

Voluntary Provident Fund: Should you invest beyond EPF? Interest rates, tax rules and the ₹2.5 lakh limit explained

VPF allows salaried employees to invest beyond mandatory EPF contributions at the prevailing 8.25% interest rate. Understand the ₹2.5 lakh tax-free interest limit, tax on excess contributions and withdrawal rules before investing more for retirement.

LiveMint — Money